Mesoblast Taps Regeneron Veteran as Clinical Chief to Expand Cell Therapy Pipeline
Mesoblast appoints veteran biotech executive Dr. Teresa Montagut as Head of Clinical Development, signaling acceleration in cell therapy pipeline expansion and Ryoncil® indication broadening.
MESOclinical developmentRyoncil®